<div id="readability-page-1"><div>AASTOCKS Financial News' compilation of the latest investment ratings, TP and views from 8 brokers on SMIC (00981.HK) -2.450 (-3.443%) Short selling $937.60M; Ratio 11.291% (688981.SH) -1.400 (-1.176%) is as follows:Brokers | Ratings | TPs | Core Views CLSA | Outperform | HKD93.3 -&gt; 94.1/ RMB152 -&gt; 153.4 1Q results were solid, with strong 2Q guidance. Benefiting from AI-driven demand, prices are expected to continue rising alongside margin improvement.HSBC Research | Buy | HKD93 -&gt; 89/ RMB153 -&gt; 146 1Q gross margin beat expectations. 2Q revenue outlook has turned more optimistic on rising shipment volume and higher ASP.BNP Paribas | Outperform | HKD86 1Q results met expectations, with upbeat 2Q guidance. Localization of AI chips will become a stronger driver, and SMIC is seen as a key beneficiary in advanced process nodes.Citi | Neutral -&gt; Buy | HKD75 -&gt; 90 Domestic substitution, AI-related demand and SMIC's leadership in advanced nodes among China's foundries will support valuation re-rating. The stock is added to the Upside 90-Day Short-Term View list.Goldman Sachs | Buy | HKD134 -&gt; 135 High capacity utilization will be maintained in 2Q, with better product mix and higher ASP supporting gross margin.Nomura | Neutral | HKD75 1Q revenue and gross margin slightly exceeded guidance. Management turned more optimistic for the full year, supported by chip shortages driving price hikes and customer front-loading.Morgan Stanley | Overweight | HKD70 1Q gross margin beat expectations, with strong 2Q guidance. As a key player in China's domestic AI chip supply chain, high capacity utilization and chip price increases can offset depreciation costs.JP Morgan | Underweight -&gt; Neutral | HKD57 -&gt; 67 1Q gross margin slightly beat expectations due to selective price hikes, with momentum extending into 2Q. However, downside risks from softer end-consumer demand in 2H warrant attention. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-18 16:25.) (A Shares quote is delayed for at least 15 mins.)</div></div>

588170

159995

159516

A compilation of investment ratings and target prices from 8 brokers on SMICshows varied opinions. CLSA and BNP Paribas rate it as Outperform, citing strong Q1 results and AI-driven demand. HSBC and Goldman Sachs recommend Buy, highlighting optimistic revenue outlooks. Citi shifts from Neutral to Buy, while Nomura remains Neutral. Morgan Stanley is Overweight, noting high capacity utilization. JP Morgan downgrades to Underweight, cautioning on potential consumer demand risks.

AASTOCKS News

ChinaAMC SSE STAR Semiconductor Material & Equipment Thematic ETF

ChinaAMC Guozheng Semiconductor Chip ETF

Guotai CSI Semiconductor Material Equipment Theme ETF

SMIC

HSBC HOLDINGS

HSBC

BNP Paribas

Citigroup

Goldman Sachs

Nomura Holdings, Inc.

Nomura

Morgan Stanley

JPMorgan Chase

SMIC HK SDR 5to1

HSBC 5xShortSG241213

HSBC Holdings Plc

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Summary of Latest Ratings, TP, Views on SMIC from Brokers